Clinical trial
Phase I/II Hypofractionated Radiotherapy for Prostate Cancer
NCT00214097 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00214097 |
|---|---|
| Title | Phase I/II Hypofractionated Radiotherapy for Prostate Cancer |
| Official title | Phase I/II Trial Examining Dose-per-Fraction Escalation Using Intensity Modulated Radiation Therapy in the Treatment of Prostate Cancer |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Radiation |
| Interventions | Radiotherapy |
| Enrollment | 347 |
| Start date | Oct 14, 2002 |
| Primary completion | Aug 21, 2017 |
| Completion | Aug 21, 2017 |
| First posted | Sep 21, 2005 |
| Last update posted | Nov 25, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: